A CASE REPORT OF A HYPERSENSITIVITY REACTION TO PEGYLATED LIPOSOMAL DOXORUBICIN (DOXIL) CAUSED BY COMPLEMENT ACTIVATION.

P84

  • Soong, W.
  • Lobo, F. M.
Annals of Allergy, Asthma, & Immunology 94(1):p 145, January 2005.
Copyright © 2005 by the American College of Allergy, Asthma, & Immunology